Articles with public access mandates - Bruce TrockLearn more
Not available anywhere: 15
Predicting 15-year prostate cancer specific mortality after radical prostatectomy
SE Eggener, PT Scardino, PC Walsh, M Han, AW Partin, BJ Trock, Z Feng, ...
The Journal of urology 185 (3), 869-875, 2011
Mandates: US National Institutes of Health
Salvage or adjuvant radiation therapy: counseling patients on the benefits
ME Nielsen, BJ Trock, PC Walsh
Journal of the National Comprehensive Cancer Network 8 (2), 228-237, 2010
Mandates: US National Institutes of Health
Is pelvic osteotomy associated with lower risk of pelvic organ prolapse in postpubertal females with classic bladder exstrophy?
I Anusionwu, N Baradaran, BJ Trock, AA Stec, JP Gearhart, EJ Wright
The Journal of urology 188 (6), 2343-2346, 2012
Mandates: US National Institutes of Health
Circulating biomarkers for discriminating indolent from aggressive disease in prostate cancer active surveillance
BJ Trock
Current opinion in urology 24 (3), 293-302, 2014
Mandates: US National Institutes of Health
Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy
LL Bañez, L Sun, BJ Trock, M Han, AW Partin, WJ Aronson, MK Terris, ...
The Journal of urology 182 (2), 491-498, 2009
Mandates: US National Institutes of Health
Practice patterns and individual variability of surgeons performing radical prostatectomy at a high volume academic center
HD Patel, E Humphreys, BJ Trock, M Han, HB Carter
The Journal of Urology 193 (3), 812-819, 2015
Mandates: US National Institutes of Health
IMPACT OF SALVAGE ANDROGEN DEPRIVATION THERAPY ON OVERALL SURVIVAL IN MEN WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: 1285
BJ Trock, M Han, SJ Freedland, EB Humphreys, AW Partin, PC Walsh
Journal of Urology 181 (4), 458, 2009
Mandates: US National Institutes of Health
Industry payments to cardiology fellows and early-career cardiologists
SS Dhruva, M Han, Y Jing, BJ Trock, SO Hogan, RF Redberg
JAMA internal medicine 184 (9), 1123-1125, 2024
Mandates: Arnold Ventures LLC
Cell cycle progression score, but not phosphatase and tensin homolog loss, is an independent prognostic factor for metastasis in intermediate-and high-risk prostate cancer in …
BJ Trock, Y Jing, B Mabey, Z Sangale, L Lenz, N Haney, I Vidal, ...
The Journal of Urology 208 (6), 1182-1193, 2022
Mandates: US Department of Defense, US National Institutes of Health
Volume-outcome relationships for kidney cancer may be driven by disparities and patient risk
JJ Wainger, JG Cheaib, HD Patel, MM Huang, MJ Biles, MR Metcalf, ...
Urologic Oncology: Seminars and Original Investigations 39 (7), 439. e1-439. e8, 2021
Mandates: US National Institutes of Health
MP43-01
C de la Calle, M Mamawala, P Landis, J Epstein, B Trock, B Carter, ...
THE JOURNAL OF UROLOGY 207 (5S), 2022
Mandates: US Department of Defense
ACTIVE SURVEILLANCE FOR SMALL RENAL MASSES IS SAFE AND NON-INFERIOR: INTERMEDIATE-TERM RESULTS FROM THE DISSRM REGISTRY: PD59-01
R Alam, HD Patel, MF Riffon, BJ Trock, P Chang, AA Wagner, ...
Journal of Urology 197 (4), e1132-e1133, 2017
Mandates: US National Institutes of Health
VARIABILITY IN GROWTH KINETICS OF SMALL RENAL MASSES ON ACTIVE SURVEILLANCE: RESULTS FROM THE DISSRM REGISTRY: PD59-02
A Uzosike, M Johnson, H Patel, M Riffon, M Gorin, C Pavlovich, P Chang, ...
Journal of Urology 197 (4), e1133, 2017
Mandates: US National Institutes of Health
COMPARATIVE EFFICACY OF EXTIRPATIVE SURGERY, THERMAL ABLATION, AND ACTIVE SURVEILLANCE FOR PATIENTS WITH SMALL RENAL MASSES: RESULTS FROM THE DISSRM REGISTRY: MP55-18
R Alam, HD Patel, A Semerjian, MF Riffon, BJ Trock, P Chang, ...
Journal of Urology 197 (4), e737-e738, 2017
Mandates: US National Institutes of Health
PATHOLOGIC STAGE AND IMPLICATIONS FOR CURE IN ACTIVE SURVEILLANCE PATIENTS WHO UNDERGO RADICAL PROSTATECTOMY: 1062
BJ Trock, Z Feng, P Landis, JI Epstein, BH Carter
Journal of Urology 183 (4), e413-e414, 2010
Mandates: US National Institutes of Health
Available somewhere: 126
Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in …
JI Epstein, Z Feng, BJ Trock, PM Pierorazio
European urology 61 (5), 1019-1024, 2012
Mandates: US National Institutes of Health
Prostate cancer–specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy
BJ Trock, M Han, SJ Freedland, EB Humphreys, TL DeWeese, AW Partin, ...
Jama 299 (23), 2760-2769, 2008
Mandates: US National Institutes of Health
Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer
JJ Tosoian, M Mamawala, JI Epstein, P Landis, S Wolf, BJ Trock, ...
Journal of Clinical Oncology 33 (30), 3379-3385, 2015
Mandates: US National Institutes of Health
An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011
JB Eifler, Z Feng, BM Lin, MT Partin, EB Humphreys, M Han, JI Epstein, ...
BJU international 111 (1), 10.1111/j. 1464-410X. 2012.11324. x, 2012
Mandates: US National Institutes of Health
The natural history of metastatic progression in men with prostate‐specific antigen recurrence after radical prostatectomy: long‐term follow‐up
ES Antonarakis, Z Feng, BJ Trock, EB Humphreys, MA Carducci, ...
BJU international 109 (1), 32-39, 2012
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program